Erik Rydstad – nyckelrekrytering med speciellt fokus på digitalisering
KPMG fortsätter att expandera teamet för rådgivning till hälso- och sjukvården och offentlig sektor och rekryterar nu Erik Rydstad. Erik har över 10 års erfarenhet som PR- och managementkonsult inom sjukvård och offentlig sektor.
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO
After securing market access and approvals in both Denmark, Sweden and UK, STENOCARE A/S (“Stenocare”) now takes a first and firm footstep into the southern hemisphere entering Australia. Partnering with the Australian medical cannabis company Cannvalate will help Stenocare embrace a hastily growing market from day one offering Stenocare products to 600 pharmacies and 3,000 doctors. A combined CBD-THC medical cannabis oil will be available for Australian patients already from fourth quarter 2022 with expected sales acceleration in the first half of 2023.
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO
STENOCARE A/S (“STENOCARE”) to make medical cannabis oil products available for UK patients. With this STENOCARE is taking a major step towards its goal of becoming a European market leader. STENOCARE has been working extensively on the regulatory approval in the UK and considers the current timing to be good given that industry analysts have projected that the UK will become one of Europe’s largest markets in five years. Delivery of first products to the UK market is expected in 60-90 days.
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO
Reference is made to today’s formal announcement, that STENOCARE has been approved by the Danish Medicines Agency to once again sell medical cannabis oil under the Danish Pilot Programme. This press release serves as an elaboration on the perspectives.
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO
STENOCARE A/S (“STENOCARE”) hereby announces that it has received approval from The Danish Medicines Agency to sell a new medical cannabis oil product to Danish patients. With this, STENOCARE once again becomes the only supplier of medical cannabis oil products under the Danish Pilot Programme.